Afaxys Pharmaceuticals is pleased to announce the important news that Afaxys and HRA Pharma have joined forces to relaunch ella® (ulipristal acetate) in the U.S.

Afaxys looks forward to supplying the U.S. marketplace with the only FDA-approved emergency contraceptive with the strength to delay ovulation for a full five days, which means extra time for extra prevention. Ella is available by prescription only and is proven safe and effective in clinical trials in over 2,000 women.1

Details related to pricing and product availability dates are still being determined. We will provide additional information as soon as we can. For the most up-to-date information, visit www.afaxys.com. To subscribe to immediate updates on pricing and product availability information, contact sales@afaxys.com.

1Reference: Ella Prescribing Information 2-2014

ella Full Prescribing Information